SCHEMBL23919153

SCHEMBL23919153

COc1ccc(-n2c3ccccc3c3c4cc(OC)c(OC)cc4c4c(c32)C=CC(c2ccc(F)cc2)(c2ccc(N3CCOCC3)cc2)O4)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.36
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
HTR7 P34969 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.33
USP2 O75604 3/20 0.33
CYP1A2 P05177 2/20 0.33
CASP1 P29466 2/20 0.33
CASP7 P55210 2/20 0.33
HIF1A Q16665 1/20 0.33
PIK3CB P42338 3/20 0.33
MAP4K1 Q92918 1/20 0.32
ALDH1A1 P00352 3/20 0.32
PIK3CA P42336 1/20 0.32
KDM4E B2RXH2 1/20 0.32
MAPT P10636 1/20 0.32
HTT P42858 1/20 0.32
ACHE P22303 1/20 0.32
BACE1 P56817 1/20 0.32
RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23919130 0.89 MAPT (0.36) POLBMEN1KMT2AHTR7L3MBTL1
SCHEMBL23919144 0.86 KDM4E (0.35) POLBMEN1KMT2AL3MBTL1ALDH1A1
SCHEMBL22145125 0.84 PPARG (0.33) POLBMEN1KMT2AUSP2CYP1A2
SCHEMBL22145201 0.81 MAPT (0.36) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL22145212 0.81
SCHEMBL23919146 0.81 MAPT (0.34) POLBMEN1KMT2AL3MBTL1USP2
SCHEMBL26937413 0.80 MAPT (0.38) MEN1KMT2AL3MBTL1ALDH1A1PIK3CA
SCHEMBL22145129 0.80 LMNA (0.36) MEN1KMT2AL3MBTL1USP2ALDH1A1
SCHEMBL22145135 0.79 EDNRA (0.36) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL22145205 0.79 EDNRA (0.34) MEN1KMT2AL3MBTL1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210317129-A1 Indolenaphthopyrans TRANSITIONS OPTICAL, LTD. (IE) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210317129-A1 Indolenaphthopyrans AHR, TDO2, TPH2 POLB 2726/4885MEN1 3107/4885KMT2A 2760/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.